<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01452295</url>
  </required_header>
  <id_info>
    <org_study_id>VTI-207</org_study_id>
    <nct_id>NCT01452295</nct_id>
  </id_info>
  <brief_title>Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion</brief_title>
  <official_title>Registry Protocol for Tracking the Incidence of Transplant, the Incidence and Type of Cancer, and Survival Rate of Subjects Participating in Protocol VTI-206 (NCT00973817)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vital Therapies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vital Therapies, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      VTI-207 (NCT01452295) is designed to follow subjects, both treated and control, for five
      years after their completion of study participation in protocol VTI-206 (NCT00973817) to
      gather information relating to the incidence of liver transplant, the incidence and type of
      cancer (if any), and survival.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vital Therapies, Inc. (VTI) is conducting clinical trial VTI-206 in which subjects with acute
      on chronic hepatitis (AOCH) and acute alcoholic hepatitis (AAH) are treated with the ELAD
      system to assess the safety and efficacy of this therapy. The ELAD system incorporates cloned
      immortalized human liver cells (C3A cells). A hypothetical risk exists that, over an extended
      period of time, there may be an increased incidence of tumor in subjects treated with ELAD.

      The company is also collecting data related to whether a patient received a liver transplant
      and on survival.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Subjects from lead-in study VTI-206 - NCT00973817 lost to follow-up before enrollment in
    VTI-207 (NCT1452295)
  </why_stopped>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gather data</measure>
    <time_frame>Five years post study participation</time_frame>
    <description>See previous description</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Acute Liver Failure</condition>
  <arm_group>
    <arm_group_label>AOCH patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with acute on chronic hepatitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AAH patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with acute alcoholic hepatitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ELAD (Extracorporeal Liver Assist System)</intervention_name>
    <description>ELAD (Extracorporeal Liver Assist System)</description>
    <arm_group_label>AOCH patients</arm_group_label>
    <arm_group_label>AAH patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects participating in the VTI-206 clinical trial.

        Exclusion Criteria:

          -  Subjects not participating in the VTI-206 clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert A Ashley</last_name>
    <role>Study Director</role>
    <affiliation>Vital Therapies, Inc.</affiliation>
  </overall_official>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2011</study_first_submitted>
  <study_first_submitted_qc>October 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2011</study_first_posted>
  <last_update_submitted>December 3, 2013</last_update_submitted>
  <last_update_submitted_qc>December 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver</keyword>
  <keyword>liver failure</keyword>
  <keyword>acute liver failure</keyword>
  <keyword>ELAD</keyword>
  <keyword>alcoholic hepatitis</keyword>
  <keyword>acute on chronic hepatitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Liver Failure, Acute</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

